The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review with network meta-analyses of randomised trials
Open accessThe DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Attention deficit hyperactivity disorder (ADHD) is one of the most commonly diagnosed psychiatric disorders in childhood. A wide variety of treatments have been used for the management of ADHD. We aimed to compare the efficacy and safety of pharmacological, psychological and complementary and alternative medicine interventions for the treatment of ADHD in children and adolescents. METHODS AND FINDINGS: We performed a systematic review with network meta-analyses. Randomised controlled trials (≥ 3 weeks follow-up) were identified from published and unpublished sources through searches in PubMed and the Cochrane Library (up to April 7, 2016). Interventions of interest were pharmacological (stimulants, non-stimulants, antidepressants, antipsychotics, and other unlicensed drugs), psychological (behavioural, cognitive training and neurofeedback) and complementary and alternative medicine (dietary therapy, fatty acids, amino acids, minerals, herbal therapy, homeopathy, and physical activity). The primary outcomes were efficacy (treatment response) and acceptability (all-cause discontinuation). Secondary outcomes included discontinuation due to adverse events (tolerability), as well as serious adverse events and specific adverse events. Random-effects Bayesian network meta-analyses were conducted to obtain estimates as odds ratios (ORs) with 95% credibility intervals. We analysed interventions by class and individually. 190 randomised trials (52 different interventions grouped in 32 therapeutic classes) that enrolled 26114 participants with ADHD were included in complex networks. At the class level, behavioural therapy (alone or in combination with stimulants), stimulants, and non-stimulant seemed significantly more efficacious than placebo. Behavioural therapy in combination with stimulants seemed superior to stimulants or non-stimulants. Stimulants seemed superior to behavioural therapy, cognitive training and non-stimulants. Behavioural therapy, stimulants and their combination showed the best profile of acceptability. Stimulants and non-stimulants seemed well tolerated. Among medications, methylphenidate, amphetamine, atomoxetine, guanfacine and clonidine seemed significantly more efficacious than placebo. Methylphenidate and amphetamine seemed more efficacious than atomoxetine and guanfacine. Methylphenidate and clonidine seemed better accepted than placebo and atomoxetine. Most of the efficacious pharmacological treatments were associated with harms (anorexia, weight loss and insomnia), but an increased risk of serious adverse events was not observed. There is lack of evidence for cognitive training, neurofeedback, antidepressants, antipsychotics, dietary therapy, fatty acids, and other complementary and alternative medicine. Overall findings were limited by the clinical and methodological heterogeneity, small sample sizes of trials, short-term follow-up, and the absence of high-quality evidence; consequently, results should be interpreted with caution. CONCLUSIONS: Clinical differences may exist between the pharmacological and non-pharmacological treatment used for the management of ADHD. Uncertainties about therapies and the balance between benefits, costs and potential harms should be considered before starting treatment. There is an urgent need for high-quality randomised trials of the multiple treatments for ADHD in children and adolescents. PROSPERO, number CRD42014015008.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“A systematic review by Catalá-López et al. [180] supports their efficacy in children, though evidence in adults remains less conclusive.”
From ADHD in Adulthood: Clinical Presentation, Comorbidities, and Treatment Perspectives (2025) · cites this paper as [180]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies have consistently demonstrated that stimulant medications are more effective than behavioral therapy or cognitive training alone in reducing symptoms [112].”
From The Impact of Social Media & Technology on Child and Adolescent Mental Health (2025) · cites this paper as [112]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Research indicates that non-stimulants are less effective than stimulant medications but can be useful for specific cases where stimulants are not suitable [112].”
From The Impact of Social Media & Technology on Child and Adolescent Mental Health (2025) · cites this paper as [112]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Atomoxetine, a selective norepinephrine reuptake inhibitor, has been found to reduce symptoms, though it typically takes longer to achieve noticeable effects compared to stimulants [112].”
From The Impact of Social Media & Technology on Child and Adolescent Mental Health (2025) · cites this paper as [112]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Two others, one combining twenty studies with over 3,000 participants, and another combining 37 studies with over 3,800 participants, found no increase in risk of all-cause treatment discontinuation in youths (Catala-Lopez et al., 2017; Schwartz and Correll, 2014).”
From The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder (2021) · cites this paper as Catala-Lopez et al., 2017
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
Self-citationDermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
Operating characteristics of a rank correlation test for publication bias
Begg, C. B., & Mazumdar, M. (1994) · Biometrics · doi:10.2307/2533446 · Cited by 16,955
Inference from iterative simulation using multiple sequences
Gelman, A., & Rubin, D. B. (1992) · Statistical Science · doi:10.1214/ss/1177011136 · Cited by 16,627
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
the CONSORT Group, Schulz, K. F., Altman, D. G., & Moher, D. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-18 · Cited by 13,371
Self-citationVos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220
Self-citationGRADE guidelines: 3. Rating the quality of evidence
Balshem, H., Helfand, M., Schünemann, H. J., Oxman, A. D., Kunz, R., Brozek, J., Vist, G. E., Falck-Ytter, Y., Meerpohl, J., & Norris, S. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.07.015 · Cited by 8,285
Hutton, B., Salanti, G., Caldwell, D. M., Chaimani, A., Schmid, C. H., Cameron, C., Ioannidis, J. P. A., Straus, S., Thorlund, K., Jansen, J. P., et al. (2015) · Annals of Internal Medicine · doi:10.7326/m14-2385 · Cited by 8,269
Self-citation
Research works printed but not linked: 2
- Attention Deficit Hyperactivity Disorder. The NICE guideline on diagnosis and management of ADHD in children, young people and adults. Leicester (UK): The British Psychological Society and The Royal College of Psychiatrists; 2009. 22420012
- Gøtzsche PC. Comments on the editorial by Sterne JA “Why the Cochrane risk of bias tool should not include funding source as a standard item”. Cochrane Library 2014 http://www.cochranelibrary.com/editorial/10.1002/14651858.ED000076 (accessed June, 2017) · DOI · Paper page
Cited by
Faraone, S. V., Banaschewski, T., Coghill, D., Zheng, Y., Biederman, J., Bellgrove, M. A., Newcorn, J. H., Gignac, M., Al Saud, N. M., Manor, I., et al. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.01.022 · Cited by 1,545
“Two others, one combining twenty studies with over 3000 participants, and another combining 37 studies with over 3800 participants, found no increase in risk of all-cause treatment discontinuation in youths (Catala-Lopez et al., 2017; Schwartz and Correll, 2014).”
Cortese, S., Adamo, N., Del Giovane, C., Mohr-Jensen, C., Hayes, A. J., Carucci, S., Atkinson, L. Z., Tessari, L., Banaschewski, T., Coghill, D., et al. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30269-4 · Cited by 1,716
Faraone, S. V. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.02.001 · Cited by 631
“AMP and MPH have been shown to exhibit comparable efficacy in 2 meta-analyses (Faraone and Glatt, 2010; Catala-Lopez et al., 2017), with other analyses reporting that AMP has moderately greater effects than MPH (Faraone and Buitelaar, 2010; Joseph et al., 2017; Stuhec et al., 2015).”
Neurodiversity at work: a biopsychosocial model and the impact on working adults
Doyle, N. (2020) · British Medical Bulletin · doi:10.1093/bmb/ldaa021 · Cited by 527
Kollins, S. H., DeLoss, D. J., Cañadas, E., Lutz, J., Findling, R. L., Keefe, R. S. E., Epstein, J. N., Cutler, A. J., & Faraone, S. V. (2020) · The Lancet Digital Health · doi:10.1016/s2589-7500(20)30017-0 · Cited by 385
Raman, S. R., Man, K. K. C., Bahmanyar, S., Berard, A., Bilder, S., Boukhris, T., Bushnell, G., Crystal, S., Furu, K., KaoYang, Y.-H., et al. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30293-1 · Cited by 329
Solmi, M., Fornaro, M., Ostinelli, E. G., Zangani, C., Croatto, G., Monaco, F., Krinitski, D., Fusar‐Poli, P., & Correll, C. U. (2020) · World Psychiatry · doi:10.1002/wps.20765 · Cited by 324
Treatment strategies for ADHD: an evidence-based guide to select optimal treatment
Caye, A., Swanson, J. M., Coghill, D., & Rohde, L. A. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0116-3 · Cited by 303
Hinshaw, S. P. (2018) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-050817-084917 · Cited by 236
Kazda, L., Bell, K., Thomas, R., McGeechan, K., Sims, R., & Barratt, A. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.5335 · Cited by 219
Correll, C. U., Cortese, S., Croatto, G., Monaco, F., Krinitski, D., Arrondo, G., Ostinelli, E. G., Zangani, C., Fornaro, M., Estradé, A., et al. (2021) · World Psychiatry · doi:10.1002/wps.20881 · Cited by 153
Zhang, M., Jia, J., Yang, Y., Zhang, L., & Wang, X. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102116 · Cited by 157
“…(Huang et al., 2022; Chen et al., 2020a; Brini et al., 2018), children or adolescences individuals with attention-deficit/hyperactivity disorder (Catal ´ a-L ´ opez et al., 2017; Seiffer et al., 2022; Zhang et al., 2020), and adults persons with substance abuse (Morais et al., 2018;…”
BackgroundDoyle, N., & McDowall, A. (2022) · Equality, Diversity and Inclusion: An International Journal · doi:10.1108/edi-06-2020-0172 · Cited by 136
An overview on neurobiology and therapeutics of attention-deficit/hyperactivity disorder
da Silva, B. S., Grevet, E. H., Silva, L. C. F., Ramos, J. K. N., Rovaris, D. L., & Bau, C. H. D. (2023) · Discover Mental Health · doi:10.1007/s44192-022-00030-1 · Cited by 115
Nazarova, V. A., Sokolov, A. V., Chubarev, V. N., Tarasov, V. V., & Schiöth, H. B. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1066988 · Cited by 111
“Moreover, it was suggested that treatment effects of behavioral therapy were larger when combined with stimulants (Catala-Lopez et al., 2017).”
BackgroundInfluentialWestwood, S. J., Raduà, J., & Rubia, K. (2021) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.190179 · Cited by 124
ADHD: Reviewing the Causes and Evaluating Solutions
Núñez-Jaramillo, L., Herrera-Solís, A., & Herrera-Morales, W. V. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11030166 · Cited by 143
Effectiveness of a digital therapeutic as adjunct to treatment with medication in pediatric ADHD
Kollins, S. H., Childress, A. C., Heusser, A. C., & Lutz, J. G. (2021) · npj Digital Medicine · doi:10.1038/s41746-021-00429-0 · Cited by 125
Bioulac, S., Micoulaud-Franchi, J.-A., Maire, J., Bouvard, M. P., Rizzo, A. A., Sagaspe, P., & Philip, P. (2020) · Journal of Attention Disorders · doi:10.1177/1087054718759751 · Cited by 91
A systematic meta-review of systematic reviews on attention deficit hyperactivity disorder
Chaulagain, A., Lyhmann, I., Halmøy, A., Widding‐Havneraas, T., Nyttingnes, O., Bjelland, I., & Mykletun, A. (2023) · European Psychiatry · doi:10.1192/j.eurpsy.2023.2451 · Cited by 111
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
Storebø, O. J., Storm, M. R. O., Ribeiro, J. P., Skoog, M., Groth, C., Edemann-Callesen, H., Schaug, J. P., Rasmussen, P. D., Huus, C.-M. L., Zwi, M., et al. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009885.pub3 · Cited by 164
Shrestha, M., Lautenschleger, J., & Soares, N. (2020) · Translational Pediatrics · doi:10.21037/tp.2019.10.01 · Cited by 71
“A network meta-analysis of about 190 randomized control trails (RCT) showed stimulants were superior to behavior therapy but combination of both medication and behavior therapy together were superior to either one (16).”
BackgroundRusca-Jordán, F., & Cortez-Vergara, C. P. (2020) · Revista de Neuro-Psiquiatría · doi:10.20453/rnp.v83i3.3794 · Cited by 331
Eating Patterns and Dietary Interventions in ADHD: A Narrative Review
Pinto, S., Correia-de-Sá, T., Sampaio-Maia, B., Vasconcelos, C., Moreira, P., & Ferreira-Gomes, J. (2022) · Nutrients · doi:10.3390/nu14204332 · Cited by 66
“Of these three, however, only behavioral therapy has shown statistically significant benefits and can be recommended as an evidence-based intervention [30,31].”
BackgroundPandian, G. S. B., Jain, A., Raza, Q., & Sahu, K. K. (2021) · Psychiatry Research · doi:10.1016/j.psychres.2021.113742 · Cited by 66
Oh, S., Choi, J., Han, D. H., & Kim, E. (2024) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-023-02174-z · Cited by 63
Johnson, J. K., Liranso, T., Saylor, K., Tulloch, G., Adewole, T., Schwabe, S., Nasser, A., Findling, R. L., & Newcorn, J. H. (2020) · Journal of Attention Disorders · doi:10.1177/1087054719836159 · Cited by 62
Drug Treatment of Epilepsy Neuropsychiatric Comorbidities in Children
Holmes, G. L. (2020) · Pediatric Drugs · doi:10.1007/s40272-020-00428-w · Cited by 67
Westwood, S. J., Criaud, M., Lam, S.-L., Lukito, S., Wallace-Hanlon, S., Kowalczyk, O. S., Kostara, A., Mathew, J. P., Agbedjro, D., Wexler, B. E., et al. (2021) · Psychological Medicine · doi:10.1017/s0033291721001859 · Cited by 74
Treatments for ADHD in Children and Adolescents: A Systematic Review
Peterson, B. S., Trampush, J. W., Maglione, M., Bolshakova, M., Rozelle, M., Miles, J. N. V., Pakdaman, S., Brown, M., Yagyu, S., Motala, A., et al. (2024) · PEDIATRICS · doi:10.1542/peds.2024-065787 · Cited by 105
Medina, R., Bouhaben, J., de Ramón, I., Cuesta, P., Antón‐Toro, L. F., Pacios, J., Quintero, J., Ramos‐Quiroga, J. A., & Maestú, F. (2021) · Journal of Medical Internet Research · doi:10.2196/25466 · Cited by 106
Trends in Antipsychotic Medication Use in Young Privately Insured Children
Bushnell, G., Crystal, S., & Olfson, M. (2020) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2020.09.023 · Cited by 60
Ferré, S., Díaz-Ríos, M., Salamone, J. D., & Prediger, R. D. (2018) · Journal of Caffeine and Adenosine Research · doi:10.1089/caff.2018.0017 · Cited by 52
O’Nions, E., Baou, C. E., John, A., Lewer, D., Mandy, W., McKechnie, D. G., Petersen, I., & Stott, J. C. H. (2025) · The British Journal of Psychiatry · doi:10.1192/bjp.2024.199 · Cited by 85
Viloxazine in the Management of CNS Disorders: A Historical Overview and Current Status
Findling, R. L., Candler, S. A., Nasser, A. F., Schwabe, S., Yu, C., Garcia-Olivares, J., O’Neal, W., & Newcorn, J. H. (2021) · CNS Drugs · doi:10.1007/s40263-021-00825-w · Cited by 55
Bioulac, S., Purper‐Ouakil, D., Ros, T., Blasco-Fontecilla, H., Prats, M., Mayaud, L., & Brandeis, D. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2218-0 · Cited by 62
Song, Y., Fan, B., Wang, C., & Yu, H. (2023) · PLOS ONE · doi:10.1371/journal.pone.0289732 · Cited by 50
Newcorn, J. H., Nagy, P., Childress, A. C., Frick, G., Yan, B., & Pliszka, S. (2017) · CNS Drugs · doi:10.1007/s40263-017-0468-2 · Cited by 50
“Although a combined systematic review and meta-analysis of studies ranging from 2 to 12 weeks in duration reported that a higher proportion of participants responded to lisdexamfetamine than methylphenidate-based agents [10], a network meta-analysis that included 190 trials ranging from 3 to 96 weeks in duration did n…”
BackgroundLeffa, D. T., Panzenhagen, A. C., Salvi, A. A., Bau, C. H. D., Pires, G. N., Torres, I. L. D. S., Rohde, L. A., Rovaris, D. L., & Grevet, E. H. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.02.019 · Cited by 54
Zhao, L., Li, X., Liu, G., Han, B., Wang, J., & Jiang, X. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s189200 · Cited by 49
Iob, E., Pingault, J., Munafo, M. R., Stubbs, B., Gilthorpe, M. S., Maihofer, A. X., & Danese, A. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02133-9 · Cited by 63
Moore, D. A., Russell, A. E., Matthews, J., Ford, T. J., Rogers, M., Ukoumunne, O. C., Kneale, D., Coon, J. T., Sutcliffe, K., Nunns, M., et al. (2018) · Review of Education · doi:10.1002/rev3.3149 · Cited by 68
Ogundele, M. O., & Ayyash, H. F. (2023) · AIMS Public Health · doi:10.3934/publichealth.2023004 · Cited by 74
Rüfenacht, E., Euler, S., Prada, P., Nicastro, R., Dieben, K., Hasler, R., Pham, E., Perroud, N., & Weibel, S. (2019) · Borderline Personality Disorder and Emotion Dysregulation · doi:10.1186/s40479-019-0108-1 · Cited by 44
Keane, J. T., Afrasiabi, A., Schibeci, S. D., Swaminathan, S., Parnell, G. P., & Booth, D. R. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103572 · Cited by 47
Lisco, G., Tullio, A. D., Iovino, M., Disoteo, O., Guastamacchia, E., Giagulli, V. A., & Triggiani, V. (2023) · Biomedicines · doi:10.3390/biomedicines11112993 · Cited by 54
Groeneveld, K. M., Mennenga, A. M., Heidelberg, R. C., Martin, R., Tittle, R. K., Meeuwsen, K. D., Walker, L. A., & White, E. K. (2019) · Applied Psychophysiology and Biofeedback · doi:10.1007/s10484-019-09439-x · Cited by 68
The Impact of Social Media & Technology on Child and Adolescent Mental Health
Masri-zada, T., Martirosyan, S., Abdou, A., Barbar, R., Kades, S., Makki, H., Haley, G., & K Agrawal, D. (2025) · Journal of Psychiatry and Psychiatric Disorders · doi:10.26502/jppd.2572-519x0242 · Cited by 45
Clark, A., Tate, B., Urban, B., Schroeder, R., Gennuso, S. A., Ahmadzadeh, S., McGregor, D., Girma, B., Shekoohi, S., & Kaye, A. D. (2023) · Health Psychology Research · doi:10.52965/001c.81043 · Cited by 52
Hoving, H., Neitzel, P., Hauss, H., Christiansen, S., Kiko, R., Robison, B. H., Silva, P., & Körtzinger, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-78255-9 · Cited by 47
Schena, A., Garotti, R., D’Alise, D., Giugliano, S., Polizzi, M., Trabucco, V., Riccio, M. P., & Bravaccio, C. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20043414 · Cited by 40
Darwin’s Other Dilemmas and the Theoretical Roots of Emotional Connection
Ludwig, R. J., & Welch, M. G. (2019) · Frontiers in Psychology · doi:10.3389/fpsyg.2019.00683 · Cited by 46
Händel, M. N., Rohde, J. F., Rimestad, M. L., Bandak, E., Birkefoss, K., Tendal, B., Lemcke, S., & Edemann-Callesen, H. (2021) · Nutrients · doi:10.3390/nu13041226 · Cited by 55
Tan, L., Li, C., Xia, J., & Jun, C. (2019) · Computers, materials & continua/Computers, materials & continua (Print) · doi:10.32604/cmc.2019.03735 · Cited by 39
Abbasi, E. (2025) · International Journal of Tropical Insect Science · doi:10.1007/s42690-025-01627-z · Cited by 53
A Review of Working Memory Training in the Management of Attention Deficit Hyperactivity Disorder
Al-Saad, M. S. H., Al-Jabri, B. A., & Almarzouki, A. F. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2021.686873 · Cited by 46
Cortese, S., Newcorn, J. H., & Coghill, D. (2021) · CNS Drugs · doi:10.1007/s40263-021-00848-3 · Cited by 38
Lim, C. G., Soh, C. P., Lim, S. S. Y., Fung, D. S. S., Guan, C., & Lee, T.-S. W. (2023) · Child and Adolescent Psychiatry and Mental Health · doi:10.1186/s13034-022-00539-x · Cited by 39
Epilepsy and Attention Deficit Hyperactivity Disorder: Connection, Chance, and Challenges
Fan, H., Chiang, K.-L., Chang, K., Chen, C., & Tsai, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065270 · Cited by 45
Pratt, M., Wieland, L. S., Ahmadzai, N., Butler, C., Wolfe, D. M., Pussagoda, K., Skidmore, B., Veroniki, A. A., Rios, P. D. L., Tricco, A. C., et al. (2020) · Systematic Reviews · doi:10.1186/s13643-020-01328-3 · Cited by 32
Self-citationFrança, A. P., Schamne, M. G., de Souza, B. S., Scheffer, D. D. L., Bernardelli, A. K., Corrêa, T., Izídio, G. S., Latini, A., da Silva‐Santos, J. E., Canas, P. M., et al. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02002-4 · Cited by 35
Prescriber's Guide – Children and Adolescents: Stahl's Essential Psychopharmacology
Stahl, S. M. (2018) · Cambridge University Press eBooks · doi:10.1017/9781108561402 · Cited by 35
Bruno, C., Havard, A., Gillies, M. B., Coghill, D., Brett, J., Guastella, A. J., Pearson, S., & Zoëga, H. (2022) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/00048674221114782 · Cited by 38
Yan, L., Zhang, J., Yuan, Y., & Cortese, S. (2018) · Medicine · doi:10.1097/md.0000000000012623 · Cited by 35
Tsujii, N., Usami, M., Naya, N., Tsuji, T., Mishima, H., Horie, J., Fujiwara, M., & Iida, J. (2021) · Neurology and Therapy · doi:10.1007/s40120-021-00249-0 · Cited by 42
Attention deficit hyperactivity disorder symptoms in patients with cystic fibrosis
Cohen‐Cymberknoh, M., Tanny, T., Breuer, O., Blau, H., Mussaffi, H., Kadosh, D., Gärtner, S., Salinas, A., Bentur, L., Nir, V., et al. (2017) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2017.11.020 · Cited by 33
Wang, C., Li, K., Seo, D., & Gaylord, S. A. (2020) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2020.102352 · Cited by 34
Neurobiology of Attention Deficit Hyperactivity Disorder
Faraone, S. V., & Radonjić, N. V. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_33-1 · Cited by 35
Türk, S., Korfmacher, A.-K., Gerger, H., der Oord, S. V., & Christiansen, H. (2023) · Clinical Psychology Review · doi:10.1016/j.cpr.2023.102271 · Cited by 37
Dodds, M., Dona, S. W. A., Gold, L. H., Coghill, D., & Le, H. (2023) · Value in Health · doi:10.1016/j.jval.2023.11.002 · Cited by 39
Sibbick, E., Boat, R., Sarkar, M., Groom, M. J., & Cooper, S. B. (2022) · Mental health and physical activity · doi:10.1016/j.mhpa.2022.100469 · Cited by 124
Faison, S. L., Fry, N., Adewole, T., Odebo, O., Wang, Z., Maletic, V., & Nasser, A. (2021) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001361 · Cited by 28
Tourism and neurodiversity: a problematisation and research agenda
Jepson, A. S., Stadler, R., & Garrod, B. (2023) · Current Issues in Tourism · doi:10.1080/13683500.2023.2233040 · Cited by 39
Baena, L. S., la Fuente, G. A. C., Martos-Cabrera, M. B., Gómez‐Urquiza, J. L., Albendín‐García, L., Romero‐Béjar, J. L., & Suleiman‐Martos, N. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10173797 · Cited by 35
Glasofer, A., & Dingley, C. (2021) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-021-01142-0 · Cited by 32
Diagnosis and treatment of children and adolescents with autism and ADHD
Hatch, B., Kadlaskar, G., & Miller, M. R. (2022) · Psychology in the Schools · doi:10.1002/pits.22808 · Cited by 34
Attention-Deficit/Hyperactivity Disorder and Transitional Aged Youth
Wilens, T. E., Isenberg, B. M., Kaminski, T. A., Lyons, R. M., & Quintero, J. (2018) · Current Psychiatry Reports · doi:10.1007/s11920-018-0968-x · Cited by 35
Viloxazine in the Treatment of Attention Deficit Hyperactivity Disorder
Edinoff, A. N., Akuly, H. A., Wagner, J. H., Boudreaux, M. A., Kaplan, L. A., Yusuf, S., Neuchat, E. E., Cornett, E. M., Boyer, A. G., Kaye, A. M., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.789982 · Cited by 30
Romero-García, P. A., Ramírez-Pérez, S., Miguel-González, J. J., Guzmán-Silahua, S., Castañeda-Moreno, J. A., Komninou, S., & Rodríguez-Lara, S. Q. (2024) · Healthcare · doi:10.3390/healthcare12151547 · Cited by 42
Frailty Assessment Predicts Acute Outcomes in Patients Undergoing Screening Colonoscopy
Taleban, S., Toosizadeh, N., Junna, S., Golden, T., Ghazala, S., Wadeea, R., Tirambulo, C., & Mohler, J. (2018) · Digestive Diseases and Sciences · doi:10.1007/s10620-018-5129-x · Cited by 22
Meta-Review: Network Meta-Analyses in Child and Adolescent Psychiatry
Cortese, S., Tomlinson, A., & Cipriani, A. (2018) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2018.07.891 · Cited by 28
Schachar, R. J. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105461 · Cited by 33
Approach to Evaluating and Managing Adult Attention-Deficit/Hyperactivity Disorder in Primary Care
Huang, H. Y., Huang, H., Spottswood, M., & Ghaemi, S. N. (2020) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000248 · Cited by 27
Lam, S.-L., Criaud, M., Alegría, A. A., Barker, G. J., Giampietro, V., & Rubia, K. (2020) · NeuroImage Clinical · doi:10.1016/j.nicl.2020.102291 · Cited by 27
Le, L. K., Shih, S. T. F., Richards‐Jones, S., Chatterton, M. L., Engel, L., Stevenson, C., Lawrence, D. M., Pépin, G., & Mihalopoulos, C. (2021) · PLoS ONE · doi:10.1371/journal.pone.0249902 · Cited by 24
Westwood, S. J., Bozhilova, N. S., Criaud, M., Lam, S.-L., Lukito, S., Wallace-Hanlon, S., Kowalczyk, O. S., Kostara, A., Mathew, J. P., Wexler, B. E., et al. (2021) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2021.12.005 · Cited by 33
Konrad, K., Gerloff, C., Kohl, S. H., Mehler, D. M. A., Mehlem, L., Volbert, E. L., Komorek, M., Henn, A. T., Boecker, M., Weiß, E. O., et al. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1286130 · Cited by 37
Shah, R., Grover, S., & Avasthi, A. (2019) · Indian Journal of Psychiatry · doi:10.4103/psychiatry.indianjpsychiatry_543_18 · Cited by 35
Faison, S. L., Fry, N., Adewole, T., Odebo, O., Schwabe, S., Wang, Z., Maletic, V., & Nasser, A. F. (2020) · Clinical Drug Investigation · doi:10.1007/s40261-020-00992-6 · Cited by 24
Munawar, K., Choudhry, F. R., Lee, S. H., Siau, C. S., Kadri, N. B. M., & Binti Sulong, R. M. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e07842 · Cited by 22
“Recent findings have shown the superiority of behavioural therapies employed with stimulants, compared to the use of stimulants or behavioural therapy alone (Catal a-L opez et al., 2017).”
BackgroundKeane, J. T., Afrasiabi, A., Schibeci, S. D., Fewings, N., Parnell, G. P., Swaminathan, S., & Booth, D. R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.732694 · Cited by 27
Attention Deficit Hyperactivity Disorder and Substance Use Disorder: A Narrative Review
Srichawla, B. S., Telles, C. C., Schweitzer, M., & Darwish, B. (2022) · Cureus · doi:10.7759/cureus.24068 · Cited by 33
Antonelli, M., & Donelli, D. (2018) · Health & Social Care in the Community · doi:10.1111/hsc.12681 · Cited by 26
Clonidine in pediatric anesthesia
Afshari, A. (2019) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000724 · Cited by 22
Catalá-López, F., Ridao-López, M., Hurtado, I., Núñez-Beltrán, A., Gènova-Maleras, R., Alonso‐Arroyo, A., Tobías, A., Aleixandre‐Benavent, R., Catalá, M. A., & Tabarés‐Seisdedos, R. (2019) · Systematic Reviews · doi:10.1186/s13643-019-1061-1 · Cited by 26
Self-citationBluschke, A., Eggert, E., Friedrich, J., Jamous, R., Prochnow, A., Pscherer, C., Schreiter, M. L., Teufert, B., Roessner, V., & Beste, C. (2022) · Journal of Cognitive Enhancement · doi:10.1007/s41465-022-00255-6 · Cited by 27
Evidence-based prescribing of medications for ADHD: where are we in 2023?
Cortese, S. (2023) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2023.2169604 · Cited by 28
Twenty years of progress in paediatric psychopharmacology: accomplishments and unmet needs
Vitiello, B., & Davico, C. (2018) · Evidence Based Mental Health · doi:10.1136/ebmental-2018-300040 · Cited by 21
Jennum, P., Hastrup, L. H., Ibsen, R., Kjellberg, J., & Simonsen, E. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.04.010 · Cited by 20
Biofeedback in pediatric populations: a systematic review and meta-analysis of treatment outcomes
Darling, K. E., Benore, E. R., & Webster, E. E. (2019) · Translational Behavioral Medicine · doi:10.1093/tbm/ibz124 · Cited by 25
Metadata
- Authors
- Catalá-López, F., Hutton, B., Núñez-Beltrán, A., Page, M. J., Ridao, M., Macías Saint-Gerons, D., Catalá, M. A., Tabarés-Seisdedos, R., & Moher, D.
- Affiliations
- Universitat de València (ES)
- University of Ottawa (CA)
- University of Bristol (GB)
- Corresponding author
- Catalá-López, Ferrán
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2017-07-12
- Volume
- 12
- Issue
- 7
- Pages
- e0180355
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC5507500
- OpenAlex
- W2735057791
- Semantic Scholar
- e66b73662b208e9cf7a659046d713a96c5f5d574
- Cited by
- 396
- References
- 102
- Citations by year
- 2026: 26 · 2025: 53 · 2024: 39 · 2023: 51 · 2022: 48 · 2021: 76 · 2020: 40 · 2019: 29 · 2018: 29 · 2017: 4
- FWCI
- 4.23
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Monash University Research Portal (Monash University) (submittedVersion, other-oa)
- RePEc: Research Papers in Economics (submittedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Repository of Digital Objects for Teaching Research and Culture (University of Valencia) (submittedVersion, cc-by-nc)
- Funders
- Fundación Alicia Koplowitz
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Social Sciences › Psychology › Developmental and Educational Psychology › Behavioral and Psychological Studies
- Social Sciences › Psychology › Neuropsychology and Physiological Psychology › Developmental and Educational Neuropsychology
- Keywords
- attention deficit hyperactivity disorder, ADHD treatment, stimulants, non-stimulant medication, methylphenidate, amphetamine, atomoxetine, guanfacine, clonidine, behavior therapy, cognitive training, neurofeedback, complementary and alternative medicine, dietary therapy, fatty acids, herbal medicine, homeopathy, physical activity, treatment efficacy, treatment acceptability, adverse events, children and adolescents
- MeSH terms
- Adolescent, Complementary Therapies, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Behavior Therapy, Central Nervous System Depressants, Child, Female, Humans, Male, Randomized Controlled Trials as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.